Bell Investment Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$946K Buy
3,761
+198
+6% +$42.6K 0.14% 62
2026
Q1
$775K Buy
3,563
+676
+23% +$150K 0.12% 66
2025
Q4
$660K Buy
2,887
+1
+0% +$228 0.1% 69
2025
Q3
$668K Sell
2,886
-7
-0.2% -$1.43K 0.11% 66
2025
Q2
$537K Buy
2,893
+813
+39% +$151K 0.09% 72
2025
Q1
$436K Buy
2,080
+19
+0.9% +$3.69K 0.08% 68
2024
Q4
$366K Sell
2,061
-8
-0.4% -$1.47K 0.07% 77
2024
Q3
$409K Buy
2,069
+6
+0.3% +$1.12K 0.07% 75
2024
Q2
$354K Sell
2,063
-1
-0% -$166 0.07% 78
2024
Q1
$376K Buy
2,064
+33
+2% +$5.69K 0.07% 75
2023
Q4
$315K Buy
2,031
+126
+7% +$18.4K 0.06% 79
2023
Q3
$284K Buy
1,905
+1,242
+187% +$182K 0.06% 78
2023
Q2
$89.3K Sell
663
-235
-26% -$34.5K 0.02% 120
2023
Q1
$143K Buy
898
+73
+9% +$11.2K 0.03% 88
2022
Q4
$133K Buy
825
+148
+22% +$22.7K 0.03% 94
2022
Q3
$91K Buy
677
+82
+14% +$11.8K 0.03% 84
2022
Q2
$91K Buy
+595
New +$90.9K 0.03% 94
2021
Q4
$77K Buy
567
+170
+43% +$20.1K 0.02% 120
2021
Q3
$43K Buy
+397
New +$45.4K 0.01% 163

Other funds holding ABBV

Bell Investment Advisors's ABBV Position: Q2 2026 in Review

Bell Investment Advisors increased its AbbVie (ABBV) stake by 5.6% in Q2 2026, buying an estimated $42.6K and bringing the position to 3,761 shares worth $946K. The position accounts for 0.14% of the portfolio, ranked #62.

Bell Investment Advisors first reported a position in ABBV in Q3 2021 and has held it in 19 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Bell Investment Advisors held 3,761 shares of AbbVie worth $946K as of Q2 2026.
  • Bell Investment Advisors bought 198 AbbVie shares in Q2 2026, an estimated $42.6K.
  • AbbVie made up 0.14% of Bell Investment Advisors's portfolio in Q2 2026, its #62 holding.
  • Bell Investment Advisors first reported a position in AbbVie in Q3 2021 and has held it in 19 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.